SCHEMBL8609686

SCHEMBL8609686

c1ccc2c(c1)Cc1cc(CCn3ccnc3)ccc1-2

nearest known ligand 0.76

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ CYP17A1 P05093 2/20 0.76
▸ HMOX1 P09601 1/20 0.48
▸ CYP19A1 P11511 4/20 0.46
▸ TBXAS1 P24557 2/20 0.46
▸ KMT2A Q03164 1/20 0.45
▸ TSHR P16473 2/20 0.44
▸ NPC1 O15118 1/20 0.44
▸ TP53 P04637 1/20 0.44
▸ MAPK1 P28482 1/20 0.44
▸ RAB9A P51151 1/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ ALDH1A1 P00352 1/20 0.42
▸ ATM Q13315 1/20 0.42
▸ NPSR1 Q6W5P4 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL8610701 0.99 CYP17A1 (0.74) CYP17A1HMOX1CYP19A1TBXAS1KMT2A
SCHEMBL8607698 0.91 CYP17A1 (0.71) CYP17A1HMOX1CYP19A1
SCHEMBL8607720 0.86 CYP17A1 (1.00) CYP17A1CYP19A1TBXAS1TSHRNPC1
SCHEMBL11005510 0.78 CYP17A1 (0.59) CYP17A1TBXAS1KMT2ANPC1RAB9A
SCHEMBL11000135 0.77 CYP17A1 (0.58) CYP17A1CYP19A1TBXAS1
Hydrochloric Acid SCHEMBL10969797 0.77 CYP17A1 (0.58) CYP17A1TBXAS1KMT2ANPC1RAB9A
SCHEMBL4816440 0.76 TBXAS1 (0.48) CYP17A1HMOX1CYP19A1TBXAS1KMT2A
SCHEMBL8612399 0.76 CYP17A1 (0.51) CYP17A1CYP19A1KMT2ATSHRNPC1
SCHEMBL7195015 0.76 GPR84 (0.60) CYP17A1TSHRNPC1TP53MAPK1
SCHEMBL11007152 0.75 CYP19A1 (0.72) HMOX1CYP19A1TBXAS1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5807880-A ANTICANCER AGENTS; DISEASES OF PROSTATE GLAND, MAMMARY GLANDS; ENDOMETRIOSIS YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1998-09-15 — — US disclosed
Send feedback